Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Tebbe

Showing results (171-180 of 206) with videos related to

Pageof 21
Sort By:
Minerva Cardioangiologica|December 15, 2006
Papillary fibroelastoma of the ascending aorta presenting with cardiogenic shockO Coskun, T Coskun, L Arusoglu, et al.
Klinische Wochenschrift|August 2, 1990
[Plasma endothelin in normal probands and patients with nephrologic-rheumatologic and cardiovascular diseases]J Schrader, U Tebbe, M Borries, et al.
American Heart Journal|October 31, 2000
Immediate stent implantation versus conventional techniques for the treatment of abrupt vessel closure or symptomatic dissections after coronary balloon angioplastyM Haude, H W Hopp, H J Rupprecht, et al.
Zeitschrift Fur Kardiologie|March 1, 1983
[Ventricular septal defect as a complication of myocardial infarct]K L Neuhaus, U Tebbe, G Sauer, et al.
Thrombosis Research|June 11, 2011
Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: an analysis of the CERTIFY studyS M Schellong, H-E Gerlach, U Tebbe, et al.
European Heart Journal|July 1, 1995
Recombinant hirudin and front-loaded alteplase in acute myocardial infarction: final results of a pilot study. HIT-I (hirudin for the improvement of thrombolysis)U Zeymer, R von Essen, U Tebbe, et al.
Journal of the American College of Cardiology|August 1, 1995
Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With SaruplaseU Tebbe, J Windeler, I Boesl, et al.
Circulation|October 1, 1994
Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)K L Neuhaus, R von Essen, U Tebbe, et al.
Thrombosis and Haemostasis|April 21, 2011
CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiencyR Bauersachs, S M Schellong, S Haas, et al.
Journal of the American College of Cardiology|April 1, 1992
Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)K L Neuhaus, R von Essen, U Tebbe, et al.
Pageof 21

Showing results (171-180 of 206) with videos related to

Sort By:
Pageof 21
Minerva Cardioangiologica|December 15, 2006
Papillary fibroelastoma of the ascending aorta presenting with cardiogenic shockO Coskun, T Coskun, L Arusoglu, et al.
Klinische Wochenschrift|August 2, 1990
[Plasma endothelin in normal probands and patients with nephrologic-rheumatologic and cardiovascular diseases]J Schrader, U Tebbe, M Borries, et al.
American Heart Journal|October 31, 2000
Immediate stent implantation versus conventional techniques for the treatment of abrupt vessel closure or symptomatic dissections after coronary balloon angioplastyM Haude, H W Hopp, H J Rupprecht, et al.
Zeitschrift Fur Kardiologie|March 1, 1983
[Ventricular septal defect as a complication of myocardial infarct]K L Neuhaus, U Tebbe, G Sauer, et al.
Thrombosis Research|June 11, 2011
Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: an analysis of the CERTIFY studyS M Schellong, H-E Gerlach, U Tebbe, et al.
European Heart Journal|July 1, 1995
Recombinant hirudin and front-loaded alteplase in acute myocardial infarction: final results of a pilot study. HIT-I (hirudin for the improvement of thrombolysis)U Zeymer, R von Essen, U Tebbe, et al.
Journal of the American College of Cardiology|August 1, 1995
Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With SaruplaseU Tebbe, J Windeler, I Boesl, et al.
Circulation|October 1, 1994
Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)K L Neuhaus, R von Essen, U Tebbe, et al.
Thrombosis and Haemostasis|April 21, 2011
CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiencyR Bauersachs, S M Schellong, S Haas, et al.
Journal of the American College of Cardiology|April 1, 1992
Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)K L Neuhaus, R von Essen, U Tebbe, et al.
Pageof 21